Actinium Pharmaceuticals, Inc. (ATNM)

Revenue

$35.09M

TTM · Period ending: · USD

ATNM logo

ATNM Revenue

Latest reported$35.09M
ATNM Revenue ($0.00 → $35.09M)
High-resolution chart · PNG

ATNM revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Revenue — Annual fiscal periods (USD)
Period endingRevenue (USD)
90,000
0
81,000
1,030,000
1,144,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.